Millennium Management LLC lessened its position in shares of Organigram Holdings Inc. (NASDAQ:OGI - Free Report) by 49.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 645,780 shares of the company's stock after selling 627,436 shares during the quarter. Millennium Management LLC owned about 0.51% of Organigram worth $1,038,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of OGI. Arrowstreet Capital Limited Partnership purchased a new position in shares of Organigram in the fourth quarter worth about $1,153,000. Dimensional Fund Advisors LP lifted its position in Organigram by 13.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company's stock worth $579,000 after buying an additional 43,721 shares in the last quarter. Oxford Asset Management LLP purchased a new stake in shares of Organigram during the fourth quarter worth $50,000. Cubist Systematic Strategies LLC increased its stake in shares of Organigram by 210.7% during the fourth quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock worth $73,000 after buying an additional 30,583 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Organigram by 2.4% during the 4th quarter. Renaissance Technologies LLC now owns 914,648 shares of the company's stock worth $1,473,000 after buying an additional 21,200 shares during the last quarter. Institutional investors own 34.63% of the company's stock.
Organigram Trading Up 2.2%
Shares of NASDAQ OGI traded up $0.03 during trading hours on Monday, reaching $1.38. The stock had a trading volume of 342,087 shares, compared to its average volume of 655,532. Organigram Holdings Inc. has a fifty-two week low of $0.85 and a fifty-two week high of $2.08. The firm has a market cap of $184.76 million, a price-to-earnings ratio of -3.63 and a beta of 1.37. The firm has a 50-day moving average of $1.16 and a 200-day moving average of $1.31.
Organigram Profile
(
Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Recommended Stories

Before you consider Organigram Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram Global wasn't on the list.
While Organigram Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.